Properties Gene, mRNA, and precursor Synthesis and release Receptors Agonists and Antagonists Biological functions Clinical implications
ChemicalBook > CAS DataBase List > ATRIAL NATRIURETIC FACTOR (1-28) (RAT)

ATRIAL NATRIURETIC FACTOR (1-28) (RAT)

Properties Gene, mRNA, and precursor Synthesis and release Receptors Agonists and Antagonists Biological functions Clinical implications
Product Name
ATRIAL NATRIURETIC FACTOR (1-28) (RAT)
CAS No.
88898-17-3
Chemical Name
ATRIAL NATRIURETIC FACTOR (1-28) (RAT)
Synonyms
RANF;RANP;ANF 1-28;ALPHA-RANP;ANP-(1-28);RANF (1-28);CARDIONATRIN;ANP 1-28, RAT;ANF (1-28), RAT;α-atriopeptin, rat
CBNumber
CB3670516
Molecular Formula
C128H205N45O39S2
Formula Weight
3062.41
MOL File
88898-17-3.mol
More
Less

ATRIAL NATRIURETIC FACTOR (1-28) (RAT) Property

Density 
1.54±0.1 g/cm3(Predicted)
storage temp. 
-20°C
solubility 
0.05 M acetic acid: 1 mg/mL, clear, colorless
Water Solubility 
Soluble to 1 mg/ml in water
Sequence
H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH(Disulfide bridge: Cys7-Cys23)
More
Less

Safety

Safety Statements 
22-24/25
WGK Germany 
3
10
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
A8208
Product name
Atrial Natriuretic Peptide rat
Purity
≥97% (HPLC)
Packaging
0.1mg
Price
$107.4
Updated
2024/03/01
Sigma-Aldrich
Product number
A8208
Product name
Atrial Natriuretic Peptide rat
Purity
≥97% (HPLC)
Packaging
0.5mg
Price
$611
Updated
2024/03/01
Usbiological
Product number
A4151
Product name
Atrial Natriuretic Peptide
Packaging
1mg
Price
$635
Updated
2021/12/16
Usbiological
Product number
517026
Product name
Atrial Natriuretic Peptide
Packaging
96Tests
Price
$879
Updated
2021/12/16
Usbiological
Product number
517028
Product name
Atrial Natriuretic Peptide
Packaging
96Tests
Price
$922
Updated
2021/12/16
More
Less

ATRIAL NATRIURETIC FACTOR (1-28) (RAT) Chemical Properties,Usage,Production

Properties

The Mr of human ANP is 3082 and the isoelectric point is about 10.7. It is freely soluble in water, ethanol, and 70% acetone, and insoluble in acetone, benzene, chloroform, and ether. ANP solution in water at >10-4M is stable for more than a year at -20°C.

Gene, mRNA, and precursor

The human ANP gene (NPPA), located on chromosome 1 (1p36.22), consists of three exons, and has AP-1, GRE, and other regulatory elements in the promoter region. Human ANP mRNA is 855 bp long (456bp coding sequence). Nppa first appeared in early bony fish by tandem duplication of the CNP3 gene (Nppc3). The gene structure and its mRNA size are well conserved among teleosts, amphibians, and mammals. Human proANP1–126 is cleaved into ANP-28 (ANP99–126) and N-terminal (NT)-proANP1–98 by the prohormone convertase, corin. ANP mRNA is detected most abundantly in the atrium. Some transcripts are found in the cardiac ventricle, brain, kidney, adrenal, lung, gonads, and lymphoid tissues in mammals. In nonmammals, the heart (atrium) is the main tissue of ANP synthesis followed by the brain, kidney, and interrenal in frogs and teleost fish.

Synthesis and release

Atrial ANP synthesis and release are stimulated principally by atrial stretch (increased blood volume) in mammals. Corticosteroids, α-adrenergic stimulation, and hypoxia also stimulate the gene expression as inferred by the presence of such responsive elements in the human gene. Increased ANP secretion in patients with congestive and ischemic heart failure is related to the atrial stretch and hypoxia, respectively. In eels, ANP release is increased more profoundly by osmotic stimulus than volemic stimulus, but the latter is a major stimulus in trout as in mammals. The regulation of ANP gene (Nppa) expression and release has not been examined in noncardiac tissues yet.

Receptors

ANP binds to the A-type natriuretic peptide receptor (NPR-A or GC-A) with high affinity (Kd=2–3 nM). NPR-A is a single-chain receptor with an extracellular ligand-binding domain, a membrane-spanning domain, and intracellular guanylyl-cyclase (GC) and kinase-like domains. The human NPR-A has 1061 aa residues with an Mr of 118,923. NPR-A appears to exist as a tetramer, although ANP is able to bind to a monomeric receptor. NPR-A has been cloned in the bullfrog and eel, and a second type of NPR-A has been found in the medaka and eel. ANP also binds to NPR-C that has only a short intracellular domain (Kd=10 pM). The human NPR-C consists of 540 aa residues with an Mr of 59,768. NPR-C appears to be generated by the exon shuffling of the GC-coupled receptor. In addition, NPR-D, the second GC-deficient receptor, has been cloned in the eel. While NPR-C is a dimeric receptor, NPR-D exists as a tetramer, as does NPR-A. After ANP binding, the GC domain of NPR-A is activated to catalyze the production of cGMP, which serves as the second messenger for biological actions. NPR-C is thought to be a clearance receptor to regulate local ANP concentration as it exists ubiquitously in various tissues, but the inhibition of adenylyl cyclase is suggested.

Agonists and Antagonists

Other cardiac NPs such as BNP and VNP are able to bind to NPR-A with high affinities while all NPs readily bind to NPR-C and NPR-D. C-ANF, an ANP analog with modified intraring sequences, is a selective agonist for NPR-C, but not for NPR-A. C-ANF administration increases plasma ANP and enhances its biological effects. Some NPs from snake venom, named DNP, and synthetic chimeric NPs are used clinically as agonists. Osteocrin containing the NP motif selectively binds to the NPR-C, but not to the NPR-A or -B. HS-142-1 isolated from a bacterium serves as a sole antagonist for ANP binding to NPR-A.

Biological functions

As expected from the secretory stimulus, ANP acts to restore a blood volume increase to normal by decreasing the levels of sodium and water in mammals. In addition to the vascular effect, ANP augments cardiac performance. In eels, the effects of ANP on the brain and intestine are much more potent and efficacious, but the effect on the kidney is less efficacious than in mammals. ANP induces weak antidiuresis in eels, but brisk diuresis in trout. Comparative studies in eels suggest that the fundamental action of ANP is on sodium extrusion, but not water. 

Clinical implications

The plasma ANP concentration is enhanced in proportion to the severity of heart failure in the New York Heart Association (NYHA) functional classification, which explains the use of the plasma ANP measurement for the diagnosis of heart failure. There are innumerable studies on the role of ANP in cardiac failure. In relation to hypertension, significant inverse correlation is detected between plasma ANP concentration and arterial pressure in humans, and the administration of ANP to hypertension patients decreases arterial pressure to a normal range. In addition, the plasma ANP concentration increases in patients with renal failure and infectious diseases.

Description

Atrial natriuretic peptide is the first cardiac hormone isolated from the atria with potent hypotensive and natriuretic/diuretic actions. It is a drug target for hypertension and cardiac/renal failure. The presence of a natriuretic factor in the rat heart was first reported in 1981; it was isolated in 1983 from the rat and human atria.

Uses

Atrial Natriuretic Peptide rat has been used:

  • In the absorption test to confirm the specificity of the anti-NP antibodies.
  • To study the effects of atrial natriuretic peptide (ANP) on renal water and sodium regulation in rats.
  • To study the integrated biological effects of ANP on myocardial infarction using mice models.

Biochem/physiol Actions

ANP production is regulated by factors associated with developmental, hormonal and hemodynamic processes. Its secretion is stimulated by atrial wall stretch, and ischemia.

Clinical Use

The plasma ANP concentration is routinely measured to diagnose cardiac failure. The N-terminal fragment of proANP (NT-proANP) is also measured for diagnosis because of its longer half-life in plasma. Synthetic human ANP (Carperitide1 or Hanp) is used for the treatment of acute heart failure. Many kits for the measurement of plasma ANP are sold by various companies. Recently, ANP has been gradually replaced by BNP for the diagnosis and treatment of cardiac failure because of its immediate secretion in the earlier phase.

Clinical Use

28-peptide, vasodilator, that increases glomerular filtration and diuresis.

storage

Store at -20°C

Structure and conformation

Human proANP consists of 126 aa residues with bioactive mature ANP at the C-terminus. Human ANP, or ANP99–126, consists of 28 aa residues with an intramolecular ring structure of 17 aa residues, as with other NPs1. Amphibians and bony fish also possess ANP, but birds, reptiles (except for turtles), cartilaginous fish, and cyclostomes do not. N-terminal truncated forms exist in the brain and an N-terminal elongated form named urodilatin is present in the kidney. The sequence identity is low in the prosegment. The mature ANP sequence is conserved (only one aa difference) in mammals, but is variable across different classes. Most ANPs of teleosts have an amidated C-terminus.

ATRIAL NATRIURETIC FACTOR (1-28) (RAT) Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

ATRIAL NATRIURETIC FACTOR (1-28) (RAT) Suppliers

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Fax
86-21-50328109
Email
3bsc@sina.com
Country
China
ProdList
15848
Advantage
69
GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Fax
86-21-61263399
Email
ymbetter@glbiochem.com
Country
China
ProdList
9981
Advantage
64
Shanghai Hanhong Scientific Co.,Ltd.
Tel
Country
China
ProdList
42982
Advantage
64
Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Country
China
ProdList
32344
Advantage
50
Tianjin heowns Biochemical Technology Co., Ltd.
Tel
400 638 7771
Email
sales@heowns.com
Country
China
ProdList
14443
Advantage
57
Cellmano Biotech Limited
Tel
0551-65326643 18156095617
Fax
0551-65326641
Email
info@cellmano.com
Country
China
ProdList
1011
Advantage
55
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Fax
051085625359
Email
sales@reading-chemicals.com
Country
China
ProdList
15185
Advantage
58
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Country
China
ProdList
51471
Advantage
80
Changzhou PBpharmaceutical R&D Co.,Ltd
Tel
0519-83990708
Fax
0519-83990708
Email
lxy2046@yeah.net
Country
China
ProdList
480
Advantage
55
Nanjing Leon Biological Technology Co., Ltd.
Tel
17705183659
Fax
84523390
Email
sales@njleonbiotech.com
Country
China
ProdList
5503
Advantage
55
Nanjing Peptide Biotech Ltd.
Tel
025-58361106-805 13082558573
Fax
025-58361106-806
Email
liugang@njpeptide.com
Country
China
ProdList
9962
Advantage
55
Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Fax
0571-87213919
Email
eric@peptidego.com
Country
China
ProdList
6347
Advantage
58
Fan De(Beijing) Biotechnology Co., Ltd.
Tel
15911056312
Email
liming@bio-fount.com
Country
China
ProdList
9730
Advantage
58
Zhejiang J&C Biological Technology Co.,Limited
Tel
+1-2135480471 +1-2135480471
Email
sales@sarms4muscle.com
Country
China
ProdList
10523
Advantage
58
Hangzhou Go Top Peptide Biotech
Tel
0571-88211921
Email
sales1@gotopbio.com
Country
CHINA
ProdList
2609
Advantage
58
Dideu Industries Group Limited
Tel
+86-29-89586680 +86-15129568250
Email
1026@dideu.com
Country
China
ProdList
28608
Advantage
58
Cellmano Biotech Limited
Tel
0551-65326643 18156095617
Fax
0551-65326641
Email
info@cellmano.com
Country
China
ProdList
999
Advantage
58
career henan chemical co
Tel
+86-0371-86658258 15093356674;
Fax
0086-371-86658258
Email
factory@coreychem.com
Country
China
ProdList
29826
Advantage
58
Nanjing chengqimei Biotechnology Co., Ltd
Tel
19850819832
Email
2173594524@qq.com
Country
China
ProdList
2638
Advantage
58
Wuxi Helen Biotechnology Co., Ltd.,
Tel
0510-85629785 18013409632
Fax
0510-85625359
Email
sales@reading-chemicals.com
Country
China
ProdList
14092
Advantage
58
Nanjing TGpeptide Biotechnology Co.,Ltd.
Tel
18115476705
Email
sales@tgpeptide.com
Country
China
ProdList
3189
Advantage
58
Ontores Biotech
Tel
0571-88760729 18072970094
Email
supports@ontorespeptide.com
Country
China
ProdList
2696
Advantage
58
Hangzhou Go Top Peptide Biotech
Tel
0571-88211921 13355716090
Email
Sales@gotopbio.com
Country
China
ProdList
2831
Advantage
58
MedBioPharmaceutical Technology Inc
Tel
021-69568360 18916172912
Email
order@med-bio.cn
Country
China
ProdList
8141
Advantage
58
cjbscvictory
Tel
13348960310 13348960310
Email
3003867561@qq.com
Country
China
ProdList
9946
Advantage
58
TCI (Shanghai) Chemical Trading Co., Ltd.
Tel
021-61109150
Fax
021-61105897
Email
sales@tcisct.com
Country
China
ProdList
31163
Advantage
58
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840
Email
psaitong@jm-bio.com
Country
China
ProdList
29778
Advantage
58
Hubei Zhaoke BIO-CHEMICAL Co., Ltd.
Tel
027-87607080 13433334465
Email
396587392@qq.com
Country
China
ProdList
347
Advantage
58
Nanjing Shizhou Biology Technology Co.,Ltd
Tel
13675144456
Email
alan.chow@synzest.com
Country
China
ProdList
9471
Advantage
58
Nanjing Yuanpeptide Biotech Co.,Ltd.
Tel
18168071971
Email
support@yuan-peptide.com
Country
China
ProdList
2977
Advantage
58
Chengdu Jinglin Biotechnology Co., Ltd.
Tel
17711399154
Email
3211919385@qq.com
Country
China
ProdList
1815
Advantage
58
Shaoxing Junyu Biotechnology Co., LTD
Tel
0571-88211921 15572296305
Email
sales4@gotopbio.com
Country
China
ProdList
5144
Advantage
58
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
Tel
0571-87213919 17306812703
Email
3007955328@qq.com
Country
China
ProdList
5950
Advantage
58
Hangzhou Baige Pharmaceutical Technology Co. , Ltd.
Tel
0571-85350119 15888826472
Email
15888826472@163.com
Country
China
ProdList
2729
Advantage
58
Shanghai HongTide Biotechnology Co.,Ltd.
Tel
19961912513
Email
sales@hongtide.com
Country
China
ProdList
4538
Advantage
58
Zhongke Huayao (Jiangsu) Biotechnology Co., Ltd
Tel
18014456767 18014456767
Email
wenxi@jszkhy.com
Country
China
ProdList
1349
Advantage
58
Combio (Suzhou) Ltd.
Tel
0512-51886999 17706251929
Email
office@combiosz.com
Country
China
ProdList
2224
Advantage
58
https://hanhongsci.com/
Tel
021-54306202 18917919676
Email
info@hanhongsci.com
Country
China
ProdList
29989
Advantage
58
Shanghai Toyang Biotechnology Co., LTD
Tel
021-59555769 13524932310
Fax
021-50342869
Email
1405894150@qq.com
Country
China
ProdList
8221
Advantage
58
Nanjing Yushengkang Biotechnology Co., Ltd
Tel
13327808530
Email
2670965693@qq.com
Country
China
ProdList
2179
Advantage
58
Zhejiang Jiekun Biotechnology Co., Ltd
Tel
0571-88211951 13735575465
Email
sales1@gotopbio.com
Country
China
ProdList
4904
Advantage
58
Guangzhou Xinyanze Biotechnology Co., LTD
Tel
18120340186
Email
3239311947@qq.com
Country
China
ProdList
375
Advantage
58
Wuhan Peptide Core Biotechnology Co., Ltd
Tel
027-65317797 13667154760
Email
1096814016@qq.com
Country
China
ProdList
9941
Advantage
58
Taiyuan Bailihengkang Biotechnology Co., Ltd
Tel
19135651983 19135651983
Email
18611134419@163.com
Country
China
ProdList
4976
Advantage
58
Phygene
Tel
18059081430
Email
2070812664@qq.com
Country
China
ProdList
1232
Advantage
58
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Tel
+86-18521732826
Email
market@aladdin-e.com
Country
China
ProdList
48467
Advantage
58
Hangzhou Beiputai Biopharmaceutical Co., Ltd
Tel
0571-85350119 13305819357
Email
bptsales@163.com
Country
China
ProdList
3609
Advantage
58
Hubei wei shi reagent group ltd., company
Tel
027-59101766 13125137661
Email
2853877621@qq.com
Country
China
ProdList
3188
Advantage
58
Shenzhen Nexconn Pharmatechs Ltd
Tel
+86-755-89396905 +86-15013857715
Email
admin@nexconn.com
Country
China
ProdList
10248
Advantage
58
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd
Tel
+86-19164747840 +86-13119157289
Email
13119157289@163.com
Country
China
ProdList
2971
Advantage
58
More
Less

View Lastest Price from ATRIAL NATRIURETIC FACTOR (1-28) (RAT) manufacturers

Career Henan Chemical Co
Product
TRIAL NATRIURETIC FACTOR (1-28) (RAT) 88898-17-3
Price
US $7.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
100kg
Release date
2020-02-18

88898-17-3, ATRIAL NATRIURETIC FACTOR (1-28) (RAT)Related Search:


  • H-SER-LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR-OH (DISULFIDE BRIDGE: 7-23)
  • ATRIAL NATRIURETIC PEPTIDE (1-28), RAT
  • ATRIAL NATRIURETIC PEPTIDE
  • ATRIAL NATRIURETIC FACTOR (1-28) (RAT)
  • A-TYPE (ATRIAL) NATRIURETIC PEPTIDE (RAT, 1-28) (RABBIT, MOUSE)
  • ATRIAL NATRIURETIC PEPTIDE, RAT
  • CARDIONATRIN
  • RANF
  • RANF (1-28)
  • RANP
  • SER-LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR
  • SER-LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR RAT
  • SER-LEU-ARG-ARG-SER-SER-(CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS)CYCLIC-ASN-SER-PHE-ARG-TYR-OH
  • SLRRSSCFGGRIDRIGAQSGLGCNSFRY
  • H-SER-LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR-OH
  • Atrial Natriuretic Factor (1-28) (mouse, rabbit, rat) H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond)
  • TRIAL NATRIURETIC FACTOR (1-28) (RAT)
  • (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(1R,7S,13S,16S,19S,25S,28S,31S,34S,37S,46S,49R)-49-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxy-propanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-5-guanidi
  • SLRRSSCFGGRIDRIGAQSGLGCNSFRY (DISULFIDE BRIDGE: 7-23)
  • atrialnatriureticfactor(1-28
  • ATRIAL NATRIURETIC PEPTIDE, RAT, 100 UG
  • α-atriopeptin, rat
  • M.W. 3062.43 C128H205N45O39S2
  • Atrial natriuretic factor【rat】
  • Atriopeptin28【rat】
  • Atriopeptin-28【rat】
  • SER-LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP- ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR(DISULFIDE BRIDGE:CYS7-CYS23)
  • SER-LEU-ARG-ARG-SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG-TYR: SLRRSSCFGGRIDRIGAQSGLGCNSFRY DISULFIDE BRIDGE CYS7-CYS23
  • SER-SER-CYS-PHE-GLY-GLY-ARG-ILE-ASP-ARG-ILE-GLY-ALA-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-ARG(DISULFIDE BRIDGE:CYS3-CYS18)
  • ANF (123-150), RAT
  • ANF (1-28), RAT
  • ANF 1-28
  • ANP (RAT, 1-28) (RABBIT, MOUSE)
  • ANP 1-28, RAT
  • ANP (123-150), RAT
  • ALPHA-ATRIOPEPTIN, RAT
  • ALPHA-ANF 1-28, RAT
  • ALPHA-ANP [1-28] RAT
  • ALPHA-RANP
  • α-Atriopeptin, rat, α-rANP, ANF (123-150), rat, ANF 1-28, rANP
  • Atrial Natriuretic Factor (1-28) (Mouse, rabbit, rat) rANF (1-28)
  • ANP-(1-28)
  • L-Tyrosine, L-seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-isoleucyl-L-α-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-, cyclic (7→23)-disulfi...
  • Atrial Natriuretic Peptide (ANP) (1-28), rat (Atrial natriuretic factor (1-28) (rat))
  • Rat atrial natriuretic factor(1-28)
  • ATRIAL NATRIURETIC FACTOR (1-28) (RAT) USP/EP/BP
  • Atrial natriuretic factor (1-28) (rat) TFA
  • Atrial Natriuretic Peptide(1-28)
  • 88898-17-3
  • C128H205N45O39S2
  • Peptides
  • Natriuretic Peptides
  • BioChemical
  • Amino Acids and Peptides
  • Biochemicals and Reagents
  • Peptide
  • Atrial Natriuretic Peptide